Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 1;13(6):a041304.
doi: 10.1101/cshperspect.a041304.

A Systematic Review of Optogenetic Vision Restoration: History, Challenges, and New Inventions from Bench to Bedside

Antonia Stefanov  1 , John G Flannery  2   3
Affiliations

A Systematic Review of Optogenetic Vision Restoration: History, Challenges, and New Inventions from Bench to Bedside

Antonia Stefanov et al. Cold Spring Harb Perspect Med. .

Abstract

Blindness due to rod-cone dystrophies is a significant comorbidity and cause of reduced quality of life worldwide. Optogenetics uses adeno-associated viral (AAV) vectors to bypass lost photoreceptors and transfect remnant cell populations of the degenerated retina aiming to restore vision via the ectopic expression of opsins. The optogenetic targeting of retinal ganglion cells (RGCs) has been remarkably successful and several studies have advanced to clinical trials over the recent years. The inner retina and specifically ON bipolar cells represent even more appealing targets due to their intrinsically coded tasks in parallel processing and fine-tuning of visual signals before reaching the output: RGCs. However, present success with pursuing inner and outer retinal cells for optogenetic vision restoration is limited by multiple factors, including AAV tropism, promoter specificity, and retinal morphofunctional remodeling. Here we provide a review of the evolution of optogenetics, its greatest challenges, and solutions from bench to bedside.

PubMed Disclaimer

References

    1. Abdeljalil J, Hamid M, Abdel-Mouttalib O, Stéphane R, Raymond R, Johan A, José S, Pierre C, Serge P. 2005. The optomotor response: a robust first-line visual screening method for mice. Vision Res 45: 1439–1446. 10.1016/j.visres.2004.12.015 - DOI - PubMed
    1. Ameline B, Tshilenge KT, Weber M, Biget M, Libeau L, Caplette R, Mendes-Madeira A, Provost N, Guihal C, Picaud S, et al. 2017. Long-term expression of melanopsin and channelrhodopsin causes no gross alterations in the dystrophic dog retina. Gene Ther 24: 735–741. 10.1038/gt.2017.63 - DOI - PubMed
    1. Batabyal S, Gajjeraman S, Pradhan S, Bhattacharya S, Wright W, Mohanty S. 2021. Sensitization of ON-bipolar cells with ambient light activatable multi-characteristic opsin rescues vision in mice. Gene Ther 28: 162–176. 10.1038/s41434-020-00200-2 - DOI - PMC - PubMed
    1. Berry MH, Holt A, Levitz J, Broichhagen J, Gaub BM, Visel M, Stanley C, Aghi K, Kim YJ, Cao K, et al. 2017. Restoration of patterned vision with an engineered photoactivatable G protein-coupled receptor. Nat Commun 8: 1–12. 10.1038/s41467-017-01990-7 - DOI - PMC - PubMed
    1. Berry MH, Holt A, Salari A, Veit J, Visel M, Levitz J, Aghi K, Gaub BM, Sivyer B, Flannery JG, et al. 2019. Restoration of high-sensitivity and adapting vision with a cone opsin. Nat Commun 10: 1221. 10.1038/s41467-019-09124-x - DOI - PMC - PubMed

Publication types

LinkOut - more resources